KEYSTONE SYMPOSIA
Aging: New Frontiers in Rejuvenation and Gerotherapeutics
Joint with: Somatic Mosaicism in Human Development, Aging, and Diseases
February 17-20, 2025 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Ashley Webb, Morgan Levine and Dario Riccardo Valenzano
Supported by Glenn Foundation for Medical Research
Important Deadlines
Early Registration Deadline: December 23, 2024
Scholarship Deadline: November 14, 2024
Short Talk Abstract Deadline: November 14, 2024
Poster Abstract Deadline: January 27, 2025
Meeting Summary
# Biochemistry, Structural and Cellular
# Developmental, Reproductive and Regenerative
The aging field has undergone a transformation in recent years. While the investigation of basic mechanisms remains a pillar in longevity research, therapeutic development in industry is rapidly accelerating. Further, new advances in machine learning and artificial intelligence have changed the way we measure and think about the aging process.
This meeting will span basic mechanisms of aging, rejuvenation strategies, and therapeutic development, with a central focus on epigenetics. Epigenetics has emerged as a central hallmark of aging and the reversible nature of epigenetic states presents an exciting opportunity for therapeutic intervention. Additionally, machine learning and artificial intelligence leverage epigenetic states to generate invaluable tools for measuring biological age. Attendees will hear from pioneers in each of these areas, representing diverse perspectives and backgrounds. Potential workshops include: “New horizons in artificial intelligence,” “Therapeutics for healthy aging,” and “The regenerative potential of stem cells in aging”. This program is a unique opportunity to bring together leaders in the aging field from academia and industry who share the common goals of promoting healthy aging and combating age-associated disease.
The conference will be co-located with the Keystone Symposium on Somatic Mosaicism in Human Development, Aging, and Diseases to enable cross-disciplinary insights and collaborations.
More information here:
